Alkem Labs appoints two senior management personnel effective Oct 12

Management Changes View source PDF Explain this filing

ALKEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.7%Reaction day

₹5205.00

prior close

₹5206.00

announcement price

After-mkt

timing

Nifty Midcap 150market+1.0%-0.3% vs market

Pharmaceuticals peers, median of 168sector-0.3%+1.0% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Midcap 150 and 1.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-0.1

15m

-0.2

30m

+0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.7+1.0-0.3-0.3+1.0

Next day

-0.3+0.9-1.2-0.3+0.1

-1.6+0.6-2.3-1.2-0.5

-3.0+0.5-3.5-1.0-2.0

-3.9-0.6-3.3-2.6-1.3

-3.7-1.9-1.7-4.0+0.4

-5.0-4.8-0.2-6.5+1.6

15d

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 168Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alkem Laboratories has appointed Mr. Laxmikant Tiwari and Mr. Nilesh Vartak as Senior Management Personnels effective October 12, 2026. Mr. Tiwari brings 27+ years of pharmaceutical operations experience with an MBA in Operations Management. Mr. Vartak has 24+ years in supply chain leadership across pharma, healthcare and consumer goods, with an MBA in Finance. Both appointments are disclosed under SEBI LODR Regulation 30. No details on prior roles or replacements were disclosed.

Likely market impact

Routine senior-level hiring; no immediate material impact on stock or shareholders unless strategic direction changes.